Karaca, BAtmaca, HAsli, KBozkurt, ECakar, BSurmeli, ZGGursoy, PKarabulut, BUzunoglu, SSezgin, C2025-04-102025-04-100923-7534http://hdl.handle.net/20.500.14701/37416EnglishCOMPARISON OF A NOVEL, LABEL-FREE, AND REAL-TIME CELL BASED SYSTEM (XCELLIGENCE) WITH A CONVENTIONAL VIABILITY ASSAY (XTT) TO DETERMINE THE ANTI-PROLIFERATIVE EFFECT OF AT-101 IN HUMAN BREAST CANCER CELLSMeeting Abstract